Cervical Cancer
1,274
239
311
523
Key Insights
Highlights
Success Rate
86% trial completion
Published Results
123 trials with published results (10%)
Research Maturity
523 completed trials (41% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
6.6%
84 terminated out of 1274 trials
86.2%
-0.3% vs benchmark
10%
127 trials in Phase 3/4
24%
123 of 523 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 523 completed trials
Clinical Trials (1274)
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Study of Pembrolizumab and Lenvatinib in Metastatic and Recurrent Cervix Cancer (LenPem Cervix)
Adaptation and Implementation of a Patient Navigation Program for Cervical Cancer Screening Across Contexts in Senegal
Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors
A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4
18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
DESTINY-PANTUMOUR04
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
The Effect of Vaginal Dilator Use
Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
Long-Term Follow-Up of HPV FOCAL Participants
Primary HPV-based Cervical Cancer Screening Algorithms in Botswana
A Proximity-incentive Strategy for Cervical Cancer Screening
Feasibility of HPV Self-Collection Kits for Cervical Cancer Screening
Early Pelvic Floor Physical Therapy for Women Undergoing Pelvic Radiation for Gynecologic Malignancies
PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer
A Pilot Study of Quantitative Tumor Oxygen Measurements in Cervical Cancer
A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) in Patients With Advanced Gynecological Malignant Tumors